Inhibition of NF-kappa B activity in mammary epithelium increases tumor latency and decreases tumor burden

Requirement of the NF-κB Subunit p65/RelA for K-Ras–Induced Lung Tumorigenesis

(2010) Daniela S. Bassères et al.   CANCER RESEARCH

Thymoquinone and cisplatin as a therapeutic combination in lung cancer: In vitro and in vivo

(2010) Syed H Jafri et al.   JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH

Nuclear Factor-κB Enhances ErbB2-Induced Mammary Tumorigenesis and Neoangiogenesis in Vivo

(2009) Manran Liu et al.   AMERICAN JOURNAL OF PATHOLOGY

Regulation and Function of NF-κB Transcription Factors in the Immune System

(2009) Sivakumar Vallabhapurapu et al.   Annual Review of Immunology

Activation of nuclear factor kappa B in mammary epithelium promotes milk loss during mammary development and infection

(2009) Linda Connelly et al.   JOURNAL OF CELLULAR PHYSIOLOGY

Requirement for NF-κB signalling in a mouse model of lung adenocarcinoma

(2009) Etienne Meylan et al.   NATURE

The canonical NF-κB pathway is required for formation of luminal mammary neoplasias and is activated in the mammary progenitor population

(2009) M A C Pratt et al.   ONCOGENE

Shared Principles in NF-κB Signaling

(2008) Matthew S. Hayden et al.   CELL

Targeting Nuclear Factor- B Activation Pathway by Thymoquinone: Role in Suppression of Antiapoptotic Gene Products and Enhancement of Apoptosis

(2008) G. Sethi et al.   MOLECULAR CANCER RESEARCH

Is NF-κB a good target for cancer therapy? Hopes and pitfalls

(2008) Véronique Baud et al.   NATURE REVIEWS DRUG DISCOVERY